ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Induced Pluripotent Stem Cells (iPSCs) Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
Published Date: July 2025
|
Report Code: QYRE-Auto-15C5854
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Induced Pluripotent Stem Cells iPSCs Market Size Status and Forecast 2021 2027
BUY CHAPTERS

Global Induced Pluripotent Stem Cells (iPSCs) Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Code: QYRE-Auto-15C5854
Report
July 2025
Pages:116
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Fujifilm Holding Corporation (CDI)
Ncardia
Astellas Pharma Inc
Fate Therapeutics, Inc
Pluricell Biotech
Cell Inspire Biotechnology
Reprocell
Sumitomo Dainippon Pharma

Induced Pluripotent Stem Cells (iPSCs) Market Size

In 2024, the global market size of Induced Pluripotent Stem Cells (iPSCs) was estimated to be worth US$ 128 million and is forecast to reach approximately US$ 285 million by 2031 with a CAGR of 12.3% during the forecast period 2025-2031.

Induced Pluripotent Stem Cells (iPSCs) Market

Induced Pluripotent Stem Cells (iPSCs) Market

Induced pluripotent stem cells (also known as iPS cells or iPSCs) are a type of pluripotent stem cell that can be generated directly from adult cells. The opportunities concerning a wide range of diseases including neurodegenerative, metabolic and cardiovascular diseases in a dish for cheaper and faster drug discovery. This may be particularly important in the context of monogenic rare hereditary diseases, where iPSCs can provide an alternative model system to compensate for the lack of a predictive in-vitro human model for drug discovery.
United States is the largest Induced Pluripotent Stem Cells (iPSCs) market with about 43% market share. Europe is follower, accounting for about 33% market share.
The key players are Fujifilm Holding Corporation (CDI), Ncardia, Sumitomo Dainippon Pharma, Astellas Pharma Inc, Fate Therapeutics, Inc, Pluricell Biotech, Cell Inspire Biotechnology, ReproCELL etc. Top 3 companies occupied about 73% market share.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Induced Pluripotent Stem Cells (iPSCs), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Induced Pluripotent Stem Cells (iPSCs).
The Induced Pluripotent Stem Cells (iPSCs) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Induced Pluripotent Stem Cells (iPSCs) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Induced Pluripotent Stem Cells (iPSCs) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation

Scope of Induced Pluripotent Stem Cells (iPSCs) Market Report

Report Metric Details
Report Name Induced Pluripotent Stem Cells (iPSCs) Market
Forecasted market size in 2031 approximately US$ 285 million
CAGR 12.3%
Forecasted years 2025 - 2031
Segment by Type
  • Human iPSCs
  • Mouse iPSCs
Segment by Application
  • Academic Research
  • Drug Development and Discovery
  • Toxicity Screening
  • Regenerative Medicine
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Fujifilm Holding Corporation (CDI), Ncardia, Sumitomo Dainippon Pharma, Astellas Pharma Inc, Fate Therapeutics, Inc, Pluricell Biotech, Cell Inspire Biotechnology, ReproCELL
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
  • Chapter 2: Revenue of Induced Pluripotent Stem Cells (iPSCs) in global and regional level.
  • Chapter 3: Detailed analysis of Induced Pluripotent Stem Cells (iPSCs) company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Induced Pluripotent Stem Cells (iPSCs) revenue, gross margin, and recent development, etc.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: Research Findings and Conclusion

FAQ for this report

What is the Induced Pluripotent Stem Cells (iPSCs) Market size in 2031?

Ans: The Induced Pluripotent Stem Cells (iPSCs) Market size in 2031 will be approximately US$ 285 million.

What is the Induced Pluripotent Stem Cells (iPSCs) Market share by region?

Ans: United States is the largest Induced Pluripotent Stem Cells (iPSCs) market with about 43% market share. Europe is follower, accounting for about 33% market share.

What is the market share of major companies in Induced Pluripotent Stem Cells (iPSCs) Market?

Ans: Top 3 companies occupied about 73% market share.

Who are the main players in the Induced Pluripotent Stem Cells (iPSCs) Market report?

Ans: The main players in the Induced Pluripotent Stem Cells (iPSCs) Market are Fujifilm Holding Corporation (CDI), Ncardia, Sumitomo Dainippon Pharma, Astellas Pharma Inc, Fate Therapeutics, Inc, Pluricell Biotech, Cell Inspire Biotechnology, ReproCELL

What are the Application segmentation covered in the Induced Pluripotent Stem Cells (iPSCs) Market report?

Ans: The Applications covered in the Induced Pluripotent Stem Cells (iPSCs) Market report are Academic Research, Drug Development and Discovery, Toxicity Screening, Regenerative Medicine, Others

What are the Type segmentation covered in the Induced Pluripotent Stem Cells (iPSCs) Market report?

Ans: The Types covered in the Induced Pluripotent Stem Cells (iPSCs) Market report are Human iPSCs, Mouse iPSCs

1 Study Coverage
1.1 Induced Pluripotent Stem Cells (iPSCs) Product Introduction
1.2 Market by Type
1.2.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Human iPSCs
1.2.3 Mouse iPSCs
1.3 Market by Application
1.3.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Academic Research
1.3.3 Drug Development and Discovery
1.3.4 Toxicity Screening
1.3.5 Regenerative Medicine
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Size Estimates and Forecasts
2.2 Induced Pluripotent Stem Cells (iPSCs) Market Size by Region: 2024 Versus 2031
2.2.1 Global Induced Pluripotent Stem Cells (iPSCs) Revenue by Region: 2020-2025
2.2.2 Global Induced Pluripotent Stem Cells (iPSCs) Revenue Forecast by Region (2026-2031)
2.2.3 Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Induced Pluripotent Stem Cells (iPSCs) Revenue by Type (2020-2031)
3.1.2 Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Induced Pluripotent Stem Cells (iPSCs) Revenue by Application (2020-2031)
3.2.2 Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Human iPSCs of Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Application
3.3.2 Mouse iPSCs of Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Application
4 Global Induced Pluripotent Stem Cells (iPSCs) by Company
4.1 Global Induced Pluripotent Stem Cells (iPSCs) Revenue by Company (2020-2025)
4.2 Global Induced Pluripotent Stem Cells (iPSCs) Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Induced Pluripotent Stem Cells (iPSCs) Companies around the World: Ranking by Revenue
4.3.2 Global Induced Pluripotent Stem Cells (iPSCs) Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Induced Pluripotent Stem Cells (iPSCs) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Induced Pluripotent Stem Cells (iPSCs) Companies Headquarters & Product Type
4.4.1 Global Induced Pluripotent Stem Cells (iPSCs) Companies Headquarters
4.4.2 Date of International Companies Enter into Induced Pluripotent Stem Cells (iPSCs) Market
4.4.3 Global Induced Pluripotent Stem Cells (iPSCs) Companies Product & Service
4.4.4 Human iPSCs Revenue Market Share of Induced Pluripotent Stem Cells (iPSCs) by Company
4.4.5 Mouse iPSCs Revenue Market Share of Induced Pluripotent Stem Cells (iPSCs) by Company
4.5 Global Induced Pluripotent Stem Cells (iPSCs) Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Fujifilm Holding Corporation (CDI)
5.1.1 Fujifilm Holding Corporation (CDI) Corporation Information
5.1.2 Fujifilm Holding Corporation (CDI) Description, Business Overview
5.1.3 Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Products Offered
5.1.4 Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Revenue and Gross Margin (2020-2025)
5.1.5 Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Revenue by Product in 2024
5.1.6 Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Revenue by Application in 2024
5.1.7 Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Revenue by Geographic Area in 2024
5.1.8 Fujifilm Holding Corporation (CDI) Recent Developments
5.2 Ncardia
5.2.1 Ncardia Corporation Information
5.2.2 Ncardia Description, Business Overview
5.2.3 Ncardia Induced Pluripotent Stem Cells (iPSCs) Products Offered
5.2.4 Ncardia Induced Pluripotent Stem Cells (iPSCs) Revenue and Gross Margin (2020-2025)
5.2.5 Ncardia Induced Pluripotent Stem Cells (iPSCs) Revenue by Product in 2024
5.2.6 Ncardia Induced Pluripotent Stem Cells (iPSCs) Revenue by Application in 2024
5.2.7 Ncardia Induced Pluripotent Stem Cells (iPSCs) Revenue by Geographic Area in 2024
5.2.8 Ncardia Recent Developments
5.3 Sumitomo Dainippon Pharma
5.3.1 Sumitomo Dainippon Pharma Corporation Information
5.3.2 Sumitomo Dainippon Pharma Description, Business Overview
5.3.3 Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Products Offered
5.3.4 Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Revenue and Gross Margin (2020-2025)
5.3.5 Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Revenue by Product in 2024
5.3.6 Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Revenue by Application in 2024
5.3.7 Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Revenue by Geographic Area in 2024
5.3.8 Sumitomo Dainippon Pharma Recent Developments
5.4 Astellas Pharma Inc
5.4.1 Astellas Pharma Inc Corporation Information
5.4.2 Astellas Pharma Inc Description, Business Overview
5.4.3 Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Products Offered
5.4.4 Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Revenue and Gross Margin (2020-2025)
5.4.5 Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Revenue by Product in 2024
5.4.6 Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Revenue by Application in 2024
5.4.7 Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Revenue by Geographic Area in 2024
5.4.8 Astellas Pharma Inc Recent Developments
5.5 Fate Therapeutics, Inc
5.5.1 Fate Therapeutics, Inc Corporation Information
5.5.2 Fate Therapeutics, Inc Description, Business Overview
5.5.3 Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Products Offered
5.5.4 Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Revenue and Gross Margin (2020-2025)
5.5.5 Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Revenue by Product in 2024
5.5.6 Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Revenue by Application in 2024
5.5.7 Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Revenue by Geographic Area in 2024
5.5.8 Fate Therapeutics, Inc Recent Developments
5.6 Pluricell Biotech
5.6.1 Pluricell Biotech Corporation Information
5.6.2 Pluricell Biotech Description, Business Overview
5.6.3 Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Products Offered
5.6.4 Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Revenue and Gross Margin (2020-2025)
5.6.5 Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Revenue by Product in 2024
5.6.6 Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Revenue by Application in 2024
5.6.7 Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Revenue by Geographic Area in 2024
5.6.8 Pluricell Biotech Recent Developments
5.7 Cell Inspire Biotechnology
5.7.1 Cell Inspire Biotechnology Corporation Information
5.7.2 Cell Inspire Biotechnology Description, Business Overview
5.7.3 Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Products Offered
5.7.4 Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Revenue and Gross Margin (2020-2025)
5.7.5 Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Revenue by Product in 2024
5.7.6 Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Revenue by Application in 2024
5.7.7 Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Revenue by Geographic Area in 2024
5.7.8 Cell Inspire Biotechnology Recent Developments
5.8 ReproCELL
5.8.1 ReproCELL Corporation Information
5.8.2 ReproCELL Description, Business Overview
5.8.3 ReproCELL Induced Pluripotent Stem Cells (iPSCs) Products Offered
5.8.4 ReproCELL Induced Pluripotent Stem Cells (iPSCs) Revenue and Gross Margin (2020-2025)
5.8.5 ReproCELL Induced Pluripotent Stem Cells (iPSCs) Revenue by Product in 2024
5.8.6 ReproCELL Induced Pluripotent Stem Cells (iPSCs) Revenue by Application in 2024
5.8.7 ReproCELL Induced Pluripotent Stem Cells (iPSCs) Revenue by Geographic Area in 2024
5.8.8 ReproCELL Recent Developments
6 North America
6.1 North America Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth 2020-2031
6.2 North America Induced Pluripotent Stem Cells (iPSCs) Market Facts & Figures by Country (2020-2031)
6.3 North America Induced Pluripotent Stem Cells (iPSCs) Revenue by Type (2020-2025)
6.4 North America Induced Pluripotent Stem Cells (iPSCs) Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Revenue by Type (2020-2025)
7.4 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Revenue by Application (2020-2025)
8 Europe
8.1 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth 2020-2031
8.2 Europe Induced Pluripotent Stem Cells (iPSCs) Market Facts & Figures by Country (2020-2031)
8.3 Europe Induced Pluripotent Stem Cells (iPSCs) Revenue by Type (2020-2025)
8.4 Europe Induced Pluripotent Stem Cells (iPSCs) Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth 2020-2031
9.2 Latin America Induced Pluripotent Stem Cells (iPSCs) Market Facts & Figures by Country (2020-2031)
9.3 Latin America Induced Pluripotent Stem Cells (iPSCs) Revenue by Type (2020-2025)
9.4 Latin America Induced Pluripotent Stem Cells (iPSCs) Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Induced Pluripotent Stem Cells (iPSCs) Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Induced Pluripotent Stem Cells (iPSCs) Revenue by Type (2020-2025)
10.4 Middle East and Africa Induced Pluripotent Stem Cells (iPSCs) Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Induced Pluripotent Stem Cells (iPSCs) Supply Chain Analysis
11.2 Induced Pluripotent Stem Cells (iPSCs) Key Raw Materials and Upstream Suppliers
11.3 Induced Pluripotent Stem Cells (iPSCs) Clients Analysis
11.4 Induced Pluripotent Stem Cells (iPSCs) Sales Channel and Sales Model Analysis
11.4.1 Induced Pluripotent Stem Cells (iPSCs) Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Induced Pluripotent Stem Cells (iPSCs) Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Induced Pluripotent Stem Cells (iPSCs) Distributors
12 Induced Pluripotent Stem Cells (iPSCs) Market Dynamics
12.1 Induced Pluripotent Stem Cells (iPSCs) Industry Trends
12.2 Induced Pluripotent Stem Cells (iPSCs) Market Drivers
12.3 Induced Pluripotent Stem Cells (iPSCs) Market Challenges
12.4 Induced Pluripotent Stem Cells (iPSCs) Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
FEATURED COMPANIES
Fujifilm Holding Corporation (CDI)
Ncardia
Astellas Pharma Inc
Fate Therapeutics, Inc
Pluricell Biotech
Cell Inspire Biotechnology
Reprocell
Sumitomo Dainippon Pharma
List of Tables
 Table 1. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 3. Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Region (US$ Million): 2024 VS 2031
 Table 4. Global Induced Pluripotent Stem Cells (iPSCs) Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Forecast by Region (2026-2031) & (US$ Million)
 Table 6. Global Induced Pluripotent Stem Cells (iPSCs) Revenue by Type (2020-2025) & (US$ Million)
 Table 7. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Forecast by Type (2026-2031) & (US$ Million)
 Table 8. Global Induced Pluripotent Stem Cells (iPSCs) Revenue by Application (2020-2025) & (US$ Million)
 Table 9. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Forecast by Application (2026-2031) & (US$ Million)
 Table 10. Induced Pluripotent Stem Cells (iPSCs) Revenue by Company (2020-2025) & (US$ Million)
 Table 11. Induced Pluripotent Stem Cells (iPSCs) Revenue Share by Company (2020-2025)
 Table 12. Ranking of Global Top Induced Pluripotent Stem Cells (iPSCs) Players by Revenue (US$ Million) in 2024
 Table 13. Global Induced Pluripotent Stem Cells (iPSCs) Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
 Table 14. Global Induced Pluripotent Stem Cells (iPSCs) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Induced Pluripotent Stem Cells (iPSCs) as of 2024)
 Table 15. Global Induced Pluripotent Stem Cells (iPSCs) Companies Headquarters
 Table 16. Date of International Companies Enter into Induced Pluripotent Stem Cells (iPSCs) Market
 Table 17. Global Induced Pluripotent Stem Cells (iPSCs) Companies Product & Service
 Table 18. Global Induced Pluripotent Stem Cells (iPSCs) Mergers & Acquisitions, Expansion Plans
 Table 19. Fujifilm Holding Corporation (CDI) Corporation Information
 Table 20. Fujifilm Holding Corporation (CDI) Description and Business Overview
 Table 21. Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Product
 Table 22. Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 23. Fujifilm Holding Corporation (CDI) Revenue Proportion of Induced Pluripotent Stem Cells (iPSCs) by Product in 2024
 Table 24. Fujifilm Holding Corporation (CDI) Revenue Proportion of Induced Pluripotent Stem Cells (iPSCs) by Application in 2024
 Table 25. Fujifilm Holding Corporation (CDI) Revenue Proportion of Induced Pluripotent Stem Cells (iPSCs) by Geographic Area in 2024
 Table 26. Fujifilm Holding Corporation (CDI) Recent Developments
 Table 27. Ncardia Corporation Information
 Table 28. Ncardia Description and Business Overview
 Table 29. Ncardia Induced Pluripotent Stem Cells (iPSCs) Product
 Table 30. Ncardia Induced Pluripotent Stem Cells (iPSCs) Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 31. Ncardia Revenue Proportion of Induced Pluripotent Stem Cells (iPSCs) by Product in 2024
 Table 32. Ncardia Revenue Proportion of Induced Pluripotent Stem Cells (iPSCs) by Application in 2024
 Table 33. Ncardia Revenue Proportion of Induced Pluripotent Stem Cells (iPSCs) by Geographic Area in 2024
 Table 34. Ncardia Recent Developments
 Table 35. Sumitomo Dainippon Pharma Corporation Information
 Table 36. Sumitomo Dainippon Pharma Description and Business Overview
 Table 37. Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Product
 Table 38. Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 39. Sumitomo Dainippon Pharma Revenue Proportion of Induced Pluripotent Stem Cells (iPSCs) by Product in 2024
 Table 40. Sumitomo Dainippon Pharma Revenue Proportion of Induced Pluripotent Stem Cells (iPSCs) by Application in 2024
 Table 41. Sumitomo Dainippon Pharma Revenue Proportion of Induced Pluripotent Stem Cells (iPSCs) by Geographic Area in 2024
 Table 42. Sumitomo Dainippon Pharma Recent Developments
 Table 43. Astellas Pharma Inc Corporation Information
 Table 44. Astellas Pharma Inc Description and Business Overview
 Table 45. Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Product
 Table 46. Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 47. Astellas Pharma Inc Revenue Proportion of Induced Pluripotent Stem Cells (iPSCs) by Product in 2024
 Table 48. Astellas Pharma Inc Revenue Proportion of Induced Pluripotent Stem Cells (iPSCs) by Application in 2024
 Table 49. Astellas Pharma Inc Revenue Proportion of Induced Pluripotent Stem Cells (iPSCs) by Geographic Area in 2024
 Table 50. Astellas Pharma Inc Recent Developments
 Table 51. Fate Therapeutics, Inc Corporation Information
 Table 52. Fate Therapeutics, Inc Description and Business Overview
 Table 53. Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Product
 Table 54. Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 55. Fate Therapeutics, Inc Revenue Proportion of Induced Pluripotent Stem Cells (iPSCs) by Product in 2024
 Table 56. Fate Therapeutics, Inc Revenue Proportion of Induced Pluripotent Stem Cells (iPSCs) by Application in 2024
 Table 57. Fate Therapeutics, Inc Revenue Proportion of Induced Pluripotent Stem Cells (iPSCs) by Geographic Area in 2024
 Table 58. Fate Therapeutics, Inc Recent Developments
 Table 59. Pluricell Biotech Corporation Information
 Table 60. Pluricell Biotech Description and Business Overview
 Table 61. Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Product
 Table 62. Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 63. Pluricell Biotech Revenue Proportion of Induced Pluripotent Stem Cells (iPSCs) by Product in 2024
 Table 64. Pluricell Biotech Revenue Proportion of Induced Pluripotent Stem Cells (iPSCs) by Application in 2024
 Table 65. Pluricell Biotech Revenue Proportion of Induced Pluripotent Stem Cells (iPSCs) by Geographic Area in 2024
 Table 66. Pluricell Biotech Recent Developments
 Table 67. Cell Inspire Biotechnology Corporation Information
 Table 68. Cell Inspire Biotechnology Description and Business Overview
 Table 69. Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Product
 Table 70. Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 71. Cell Inspire Biotechnology Revenue Proportion of Induced Pluripotent Stem Cells (iPSCs) by Product in 2024
 Table 72. Cell Inspire Biotechnology Revenue Proportion of Induced Pluripotent Stem Cells (iPSCs) by Application in 2024
 Table 73. Cell Inspire Biotechnology Revenue Proportion of Induced Pluripotent Stem Cells (iPSCs) by Geographic Area in 2024
 Table 74. Cell Inspire Biotechnology Recent Developments
 Table 75. ReproCELL Corporation Information
 Table 76. ReproCELL Description and Business Overview
 Table 77. ReproCELL Induced Pluripotent Stem Cells (iPSCs) Product
 Table 78. ReproCELL Induced Pluripotent Stem Cells (iPSCs) Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 79. ReproCELL Revenue Proportion of Induced Pluripotent Stem Cells (iPSCs) by Product in 2024
 Table 80. ReproCELL Revenue Proportion of Induced Pluripotent Stem Cells (iPSCs) by Application in 2024
 Table 81. ReproCELL Revenue Proportion of Induced Pluripotent Stem Cells (iPSCs) by Geographic Area in 2024
 Table 82. ReproCELL Recent Developments
 Table 83. North America Induced Pluripotent Stem Cells (iPSCs) Revenue by Country (2020-2025) & (US$ Million)
 Table 84. North America Induced Pluripotent Stem Cells (iPSCs) Revenue by Country (2026-2031) & (US$ Million)
 Table 85. North America Induced Pluripotent Stem Cells (iPSCs) Revenue by Type (2020-2025) & (US$ Million)
 Table 86. North America Induced Pluripotent Stem Cells (iPSCs) Revenue by Application (2020-2025) & (US$ Million)
 Table 87. Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Revenue by Region (2020-2025) & (US$ Million)
 Table 88. Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Revenue by Region (2026-2031) & (US$ Million)
 Table 89. Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Revenue by Type (2020-2025) & (US$ Million)
 Table 90. Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Revenue by Application (2020-2025) & (US$ Million)
 Table 91. Europe Induced Pluripotent Stem Cells (iPSCs) Revenue by Country (2020-2025) & (US$ Million)
 Table 92. Europe Induced Pluripotent Stem Cells (iPSCs) Revenue by Country (2026-2031) & (US$ Million)
 Table 93. Europe Induced Pluripotent Stem Cells (iPSCs) Revenue by Type (2020-2025) & (US$ Million)
 Table 94. Europe Induced Pluripotent Stem Cells (iPSCs) Revenue by Application (2020-2025) & (US$ Million)
 Table 95. Latin America Induced Pluripotent Stem Cells (iPSCs) Revenue by Country (2020-2025) & (US$ Million)
 Table 96. Latin America Induced Pluripotent Stem Cells (iPSCs) Revenue by Country (2026-2031) & (US$ Million)
 Table 97. Latin America Induced Pluripotent Stem Cells (iPSCs) Revenue by Type (2020-2025) & (US$ Million)
 Table 98. Latin America Induced Pluripotent Stem Cells (iPSCs) Revenue by Application (2020-2025) & (US$ Million)
 Table 99. Middle East and Africa Induced Pluripotent Stem Cells (iPSCs) Revenue by Country (2020-2025) & (US$ Million)
 Table 100. Middle East and Africa Induced Pluripotent Stem Cells (iPSCs) Revenue by Country (2026-2031) & (US$ Million)
 Table 101. Middle East and Africa Induced Pluripotent Stem Cells (iPSCs) Revenue by Type (2020-2025) & (US$ Million)
 Table 102. Middle East and Africa Induced Pluripotent Stem Cells (iPSCs) Revenue by Application (2020-2025) & (US$ Million)
 Table 103. Induced Pluripotent Stem Cells (iPSCs) Key Raw Materials, Industry Status and Trend
 Table 104. Induced Pluripotent Stem Cells (iPSCs) Key Raw Materials and Upstream Suppliers
 Table 105. Induced Pluripotent Stem Cells (iPSCs) Clients Status and Trend
 Table 106. Induced Pluripotent Stem Cells (iPSCs) Typical Clients
 Table 107. Induced Pluripotent Stem Cells (iPSCs) Distributors
 Table 108. Induced Pluripotent Stem Cells (iPSCs) Market Trends
 Table 109. Induced Pluripotent Stem Cells (iPSCs) Market Drivers
 Table 110. Induced Pluripotent Stem Cells (iPSCs) Market Challenges
 Table 111. Induced Pluripotent Stem Cells (iPSCs) Market Restraints
 Table 112. Research Programs/Design for This Report
 Table 113. Key Data Information from Secondary Sources
 Table 114. Key Data Information from Primary Sources


List of Figures
 Figure 1. Induced Pluripotent Stem Cells (iPSCs) Product Picture
 Figure 2. Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
 Figure 3. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Type in 2024 & 2031
 Figure 4. Human iPSCs Product Picture
 Figure 5. Mouse iPSCs Product Picture
 Figure 6. Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
 Figure 7. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Application in 2024 & 2031
 Figure 8. Academic Research
 Figure 9. Drug Development and Discovery
 Figure 10. Toxicity Screening
 Figure 11. Regenerative Medicine
 Figure 12. Others
 Figure 13. Induced Pluripotent Stem Cells (iPSCs) Report Years Considered
 Figure 14. Global Induced Pluripotent Stem Cells (iPSCs) Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Induced Pluripotent Stem Cells (iPSCs) Market Size (2020-2031) & (US$ Million)
 Figure 16. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Region: 2024 Versus 2031
 Figure 17. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Region (2020-2031)
 Figure 18. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share Forecast by Type (2020-2031)
 Figure 19. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share Forecast by Application (2020-2031)
 Figure 20. Human iPSCs of Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Application, 2024 VS 2031
 Figure 21. Mouse iPSCs of Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Application, 2024 VS 2031
 Figure 22. Induced Pluripotent Stem Cells (iPSCs) Revenue Share by Company (2024)
 Figure 23. Induced Pluripotent Stem Cells (iPSCs) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 24. Human iPSCs Revenue Proportion by Company in 2024
 Figure 25. Mouse iPSCs Revenue Proportion by Company in 2024
 Figure 26. North America Induced Pluripotent Stem Cells (iPSCs) Revenue 2020-2031 (US$ Million)
 Figure 27. North America Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Type (2020-2025)
 Figure 28. North America Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Application (2020-2025)
 Figure 29. Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Revenue 2020-2031 (US$ Million)
 Figure 30. Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Region (2020-2031)
 Figure 31. Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Type (2020-2025)
 Figure 32. Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Application (2020-2025)
 Figure 33. Europe Induced Pluripotent Stem Cells (iPSCs) Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 34. Europe Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Country (2020-2031)
 Figure 35. Europe Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Type (2020-2025)
 Figure 36. Europe Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Application (2020-2025)
 Figure 37. Latin America Induced Pluripotent Stem Cells (iPSCs) Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 38. Latin America Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Country (2020-2031)
 Figure 39. Latin America Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Type (2020-2025)
 Figure 40. Latin America Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Application (2020-2025)
 Figure 41. Middle East and Africa Induced Pluripotent Stem Cells (iPSCs) Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 42. Middle East and Africa Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Country (2020-2031)
 Figure 43. Middle East and Africa Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Type (2020-2025)
 Figure 44. Middle East and Africa Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Application (2020-2025)
 Figure 45. Induced Pluripotent Stem Cells (iPSCs) Supply Chain (Upstream and Downstream Market)
 Figure 46. Global Production Market Share of Induced Pluripotent Stem Cells (iPSCs) Raw Materials by Region in 2024
 Figure 47. Induced Pluripotent Stem Cells (iPSCs) Distribution Channels
 Figure 48. Global Induced Pluripotent Stem Cells (iPSCs) Percentage 2020-2031: Indirect Sales VS Direct Sales
 Figure 49. Global Induced Pluripotent Stem Cells (iPSCs) Percentage 2020-2031: Online Sales VS Offline Sales
 Figure 50. Bottom-up and Top-down Approaches for This Report
 Figure 51. Data Triangulation
 Figure 52. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5900

This license allows only one user to access the PDF.
Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

Global Human Induced Pluripotent Stem Cells iPSCs Market Research Report 2024
Global Induced Pluripotent Stem Cells iPSCs Culture Medium Market Research Report 2024
Global iPSC Generation Kit Market Research Report 2025
Global iPSC Kit Market Research Report 2025
Global Induced Pluripotent Stem Cells Service Market Research Report 2024
Global iPSC Cell Therapies Market Research Report 2025
Global Induced Pluripotent Stem Cells Production Market Research Report 2025
Global IPS Cell Differentiation Kit Market Research Report 2025
Global Induced Pluripotent Stem Cell iPSC Reprogramming Kit Market Research Report 2025
Global iPSC Differentiation Kit Market Research Report 2025
Global iPSC Characterization Kit Market Research Report 2025
Global Human iPS Cell Characterization Kit Market Research Report 2025
Global iPSCs Expansion Medium Market Research Report 2024
Global IPS Cell derived Platelets Market Research Report 2025
Global Stem Cell Services Market Insights Forecast to 2030
Global Stem Cell Research Antibodies Market Research Report 2024
Global Human Embryonic Stem Cells HESC Market Research Report 2024
Stem Cell Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Synthetic Stem Cells Market Insights Forecast to 2030
Global Mouse Embryonic Stem Cell Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions